PROSYSTEM® RCE
Porcine Rotavirus Vaccine
Modified-Live Virus
Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid
Product Description
An aid in prevention of rotaviral diarrhea, enterotoxemia and colibacillosis in nursing pigs of vaccinated sows/gilts. Unique rotavirus and seven-way scours protection. Includes two major rotavirus serotypes G4 and G5 of Serogroup A. Freeze-dried MLV vaccine with bacterin/toxoid diluent.
Indications
For use in healthy pregnant swine as an aid in the prevention of rotaviral diarrhea, enterotoxemia and colibacillosis in their nursing piglets. Contains two major Rotavirus serotypes, four major E. coli pilus antigens (K88, K99, F41 and 987P) and C. perfringens type C toxoid.
Advantages
- First USDA-licensed vaccine with two serotypes of serogroup A rotavirus; G5 (A1) and G4 (A2); for best protection
- Backpassage studies on MLV rotavirus demonstrates it cannot induce disease
- Contains four major E. coli pilus antigens (K88, K99, F41 and 987P)
- Cell free C. perfringens type C toxoid provides broader scours protection for reduced death loss
- Bacterin-toxoid adjuvanted to heighten and prolong the immune response
- Convenient 2 mL intramuscular (IM) dose
Downloads
For additional information, please see the product label.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global